ClinicalTrials.gg
Sign In

Prolactinoma clinical trials

The registry lists 28 studies for Prolactinoma across more than 10 countries. 5 are recruiting or about to start. 18 of them are mainly about Prolactinoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-23.

Get an email when these change. Save the Prolactinoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
9
Status unknown
9
Recruiting
5
Terminated
2
Active, not recruiting
2
Withdrawn
1

Phase

Phase 2
5
Phase 4
2
Phase 3
2
Phase 1
2

Where

United States
7
Brazil
4
China
3
France
2
Korea, Republic of
2
Canada
2

Who runs them

Zhebao Wu (3) · Cedars-Sinai Medical Center (2) · University Hospital, Basel, Switzerland (2) · Hospices Civils de Lyon (2) · Universidade Federal do Rio de Janeiro (2) · Seoul National University Hospital (2) · University of Alberta (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

What is being tested here

Drugs under test in Prolactinoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cabergoline225
Ropinirole001
Lapatinib001
Pasireotide011
Clomiphene001
RG-4733001
Medication001
Temozolomide001

Drug classes tested here Dopamine agonists 2 open

Coming up

1phase 3 study under way
2studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2, phase 3 first

Who these studies take

Of the 5 Prolactinoma studies recruiting now, 3 (60%) set no upper age limit and 2 (40%) stop at 75 or younger. 1 (20%) take children under 18. 1 (20%) are for women only and 0 (0%) for men only; 1 (20%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
101 (20%)1 (20%)
185 (100%)4 (80%)
305 (100%)4 (80%)
405 (100%)4 (80%)
505 (100%)4 (80%)
654 (80%)3 (60%)
753 (60%)2 (40%)
853 (60%)2 (40%)

Across all 28 studies, recruiting or not: 43% stop at 75 or younger and 21% at 65; 21% take children; 14% are for women only and 4% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 28 of 28. search them.